Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Ten months earlier, the Phase 3 Exenatide-PD3 trial had reached the same conclusion in Parkinsons disease: no effect on progression across 194 patients followed for 96 weeks, with no treatment difference on dopamine-transporter imaging in the trials imaging substudy [2]
P.KearnsG
Who Should Consider Which Choose based on what you can access safely today, not just trial percentages
Slows Down Stomach Emptying This leads to feelings of fullness and potentially reducing calorie intake
US$ 29.92
US$ 20.33
US$ 20.41
US$ 24.03
US$ 29.07
US$ 29.06
US$ 27.34
US$ 25.04
US$ 26.45
US$ 25.00
